Videx EC Interactions
There are 246 drugs known to interact with Videx EC (didanosine), along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 21 are major, 189 are moderate, and 36 are minor.
- View all 246 medications that may interact with Videx EC
- View Videx EC alcohol/food interactions (3)
- View Videx EC disease interactions (8)
Most frequently checked interactions
View interaction reports for Videx EC (didanosine) and the medicines listed below.
- acyclovir
- allopurinol
- Altace (ramipril)
- amitriptyline
- amlodipine
- ampicillin
- AndroGel (testosterone)
- Artane (trihexyphenidyl)
- atenolol
- Ativan (lorazepam)
- Atrovent (ipratropium)
- Avandia (rosiglitazone)
- beclomethasone
- benazepril
- buspirone
- Cardizem (diltiazem)
- Epivir (lamivudine)
- gabapentin
- Hytrin (terazosin)
- Kaletra (lopinavir / ritonavir)
- lamivudine
- lisinopril
- Norvasc (amlodipine)
- Norvir (ritonavir)
- pravastatin
- Prezista (darunavir)
- Sustiva (efavirenz)
- tamoxifen
- Viread (tenofovir disoproxil)
- Zerit (stavudine)
Videx EC alcohol/food interactions
There are 3 alcohol/food interactions with Videx EC (didanosine).
Videx EC disease interactions
There are 8 disease interactions with Videx EC (didanosine) which include:
- renal dysfunction
- bone marrow suppression
- hepatotoxicity
- pancreatitis
- peripheral neuropathy
- hyperuricemia
- PKU
- sodium
Report options
QR code containing a link to this page
More about Videx EC (didanosine)
- Videx EC consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
